Abstract
One year after being diagnosed with Stage I pulmonary sarcoidosis by lymph node extraction, a 58-years old female patient without a history of heart disease presented with shortness of breath, fatigue, N-terminal prohormone of brain natriuretic peptide (NT-proBNP) levels of 11 865 pg/mL (Panels A1–3, light green arrows) and late gadolinium enhancement (LGE; Panel A4, red arrow) in the septal and posterior wall of the left ventricle, confirming the diagnosis of cardiac sarcoidosis (CS). Heart failure medication with spironolactone, sacubitril/valsartan, bisoprolol, and high doses of corticosteroids (methylprednisolone 80 mg/day) was initiated. In addition, the patient was provided with an external defibrillation vest for markedly reduced systolic function and active inflammation in cardiac sarcoidosis.